Giant cell tumor of lower end of tibia.
Bami M, Nayak AR, Kulkarni S, Kulkarni A, Gupta R.
Case Rep Orthop. 2013;2013:429615. doi: 10.1155/2013/429615. Epub 2013 Jun 17.
Giant cell tumor of soft tissue: GCT arising from periosteum of tibia.
Ahmed SK, Shehzad MN.
Pak J Med Sci. 2024 Jan;40(2ICON Suppl):S97-S99. doi: 10.12669/pjms.40.2(ICON).8959.
Atypical "Sclerosing" Osteoblastic Neoplasm: A Tumor of Intermediate Biological Potential Between Usual Osteoblastoma and Conventional Osteosarcoma.
McHugh KE, Reith JD, Lucas DR, Emory CL, Mesko NW, Kilpatrick SE.
Am J Surg Pathol. 2019 May;43(5):610-617. doi: 10.1097/PAS.0000000000001236.
Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
Rekhi B, Verma V, Gulia A, Jambhekar NA, Desai S, Juvekar SL, Bajpai J, Puri A.
Pathol Oncol Res. 2017 Jan;23(1):157-164. doi: 10.1007/s12253-016-0123-0. Epub 2016 Oct 8.
[Fibrocartilaginous mesenchymoma: a clinicopathological analysis of four cases].
Huang J, Luo YL, Bai YQ, Jiao Q, Chen J, Jiang ZM, Liu ZY, Zhang HZ.
Zhonghua Bing Li Xue Za Zhi. 2023 Jan 8;52(1):25-30. doi: 10.3760/cma.j.cn112151-20221026-00886.
